ENYO Pharma Patents – Insights & Stats (Updated 2026)

ENYO Pharma has a total of 206 patents globally, out of which 52 have been granted. Of these 206 patents, more than 59% patents are active. United States of America is where ENYO Pharma has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, Europe (EPO) seems to be the main focused R&D centre and France is the origin country of ENYO Pharma.

ENYO Pharma founded in 2014, ENYO Pharma is a clinical-stage biopharmaceutical company focused on developing innovative fibrolytic and anti-inflammatory therapies for kidney diseases. Its lead candidate, Vonafexor, is currently in Phase 2 trials for chronic kidney disease and rare conditions such as Alport syndrome.

Do read about some of the most popular patents of ENYO Pharma which have been covered by us in this article and also you can find ENYO Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ENYO Pharma patent portfolio.

How many patents does ENYO Pharma have?

ENYO Pharma has a total of 206 patents globally. These patents belong to 27 unique patent families. Out of 206 patents, 121 patents are active.

How Many Patents did ENYO Pharma File Every Year?

ENYO Pharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantENYO Pharma Applications FiledENYO Pharma Patents Granted
2025113
2024129
20231117
20224212
2021401
202058
201932
201710

How many ENYO Pharma patents are Alive/Dead?

Worldwide Patents

ENYO Pharma Patent Portfolio

How Many Patents did ENYO Pharma File in Different Countries?

ENYO Pharma Worldwide Patent Filing Trend

Countries in which ENYO Pharma Filed Patents

CountryPatents
United States of America21
Europe (EPO)19
Canada16
Korea (South)13
China13
Australia12
Mexico12
Israel11
Japan11
Hong Kong (S.A.R.)9
India5
Germany5
Brazil5
South Africa5
Spain4
Philippines3
Singapore3
New Zealand3
Malaysia3
Indonesia2
Poland1
Taiwan1
Italy1
Austria1
Colombia1
Viet Nam1

Where are Research Centres of ENYO Pharma Patents Located?

R&D Centers of ENYO Pharma

10 Best Patents ENYO Pharma

WO2019154956A1 is the most popular patent in the ENYO Pharma portfolio. It has received 23 citations so far from company like Gilead Sciences Inc, Vertex Pharmaceuticals Inc and Inipharm Inc.

Below is the list of 10 most cited patents of ENYO Pharma:

Publication NumberCitation Count
WO2019154956A123
WO2019154953A120
US20210038566A111
WO2022152770A17
WO2019154950A16
WO2021074357A15
WO2019154949A15
WO2021009332A14
WO2018122317A14
WO2022029210A13

What Percentage of ENYO Pharma US Patent Applications were Granted?

ENYO Pharma (Excluding its subsidiaries) has filed 20 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7 have been granted leading to a grant rate of 87.5%.

Below are the key stats of ENYO Pharma patent prosecution at the USPTO.

EA Stats

Which Law Firms are managing US Patents for ENYO Pharma?

Law FirmTotal ApplicationsSuccess Rate
Saliwanchik Lloyd & Eisenschenk2087.50%

What are ENYO Pharma key innovation segments?

What Technologies are Covered by ENYO Pharma?

The chart below distributes patents filed by ENYO Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where ENYO Pharma thinks it’s important to protect particular technological inventions.

R&D Focus: How has ENYO Pharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by ENYO Pharma?

Related Articles

Was this article helpful?

Leave a Comment

Upcoming Global Patent and Innovation Leadership Report - 2026

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.